1.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124-36.
2.
Das A, McGuire PG, Rangasamy S. Diabetic Macular Edema: Pathophysiology and Novel
Therapeutic Targets. Ophthalmology. 2015;122(7):1375-94.
3.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence
and major risk factors of diabetic retinopathy. Diabetes care. 2012;35(3):556-64.
4.
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes.
2005;54(6):1615-25.
5.
Jampol LM, Bressler NM, Glassman AR. Revolution to a new standard treatment of diabetic
macular edema. Jama. 2014;311(22):2269-70.
6.
Pacella E, La Torre G, Impallara D, Malarska K, Turchetti P, Brillante C, et al. Efficacy
and safety of the intravitreal treatment of diabetic macular edema with pegaptanib:
a 12-month follow-up. La Clinica terapeutica. 2013;164(2):e121-6.
7.
Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, et al. Optical
coherence tomography measurements and analysis methods in optical coherence tomography
studies of diabetic macular edema. Ophthalmology. 2008;115(8):1366-71, 71 e1.
8.
Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, et al.
Three-year outcomes of individualized ranibizumab treatment in patients with diabetic
macular edema: the RESTORE extension study. Ophthalmology. 2014;121(5):1045-53.
9.
Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Long-term outcomes
of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase
III trials: RISE and RIDE. Ophthalmology. 2013;120(10):2013-22.
10.
Byeon SH, Chu YK, Hong YT, Kim M, Kang HM, Kwon OW. New insights into the pathoanatomy
of diabetic macular edema: angiographic patterns and optical coherence tomography.
Retina (Philadelphia, Pa). 2012;32(6):1087-99.
11.
Mishra M, Kowluru RA. Retinal mitochondrial DNA mismatch repair in the development
of diabetic retinopathy, and its continued progression after termination of hyperglycemia.
Investigative ophthalmology & visual science. 2014;55(10):6960-7.
12.
Prager SG, Lammer J, Mitsch C, Hafner J, Pemp B, Scholda C, et al. Analysis of retinal
layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
Acta ophthalmologica. 2018;96(2):e195-e200.
13.
Wang Q, Li T, Wu Z, Wu Q, Ke X, Luo D, et al. Novel VEGF decoy receptor fusion protein
conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect
in vivo. PloS one. 2013;8(8):e70544.
14.
Li X, Xu G, Wang Y, Xu X, Liu X, Tang S, et al. Safety and efficacy of conbercept
in neovascular age-related macular degeneration: results from a 12-month randomized
phase 2 study: AURORA study. Ophthalmology. 2014;121(9):1740-7.
15.
Zhang Z, Yang X, Jin H, Qu Y, Zhang Y, Liu K, et al. Changes in Retinal Nerve Fiber
Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept
for Various Retinal Diseases. Scientific reports. 2016;6:38326.
16.
Midena E, Vujosevic S, Cavarzeran F, Microperimetry Study G. Normal values for fundus
perimetry with the microperimeter MP1. Ophthalmology. 2010;117(8):1571-6, 6 e1.
17.
Midena E, Vujosevic S, Convento E, Manfre A, Cavarzeran F, Pilotto E. Microperimetry
and fundus autofluorescence in patients with early age-related macular degeneration.
The British journal of ophthalmology. 2007;91(11):1499-503.
18.
Chalam KV, Bressler SB, Edwards AR, Berger BB, Bressler NM, Glassman AR, et al. Retinal
thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg
Spectralis optical coherence tomography. Investigative ophthalmology & visual science.
2012;53(13):8154-61.
19.
Su L, Ren X, Wei H, Zhao L, Zhang X, Liu J, et al. INTRAVITREAL CONBERCEPT (KH902)
FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY. Retina (Philadelphia,
Pa). 2016;36(5):938-43.
20.
Chen X, Li J, Li M, Zeng M, Li T, Xiao W, et al. KH902 suppresses high glucose-induced
migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.
Diabetes, obesity & metabolism. 2013;15(3):224-33.
21.
Bolz M, Ritter M, Schneider M, Simader C, Scholda C, Schmidt-Erfurth U. A systematic
correlation of angiography and high-resolution optical coherence tomography in diabetic
macular edema. Ophthalmology. 2009;116(1):66-72.
22.
Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis
in the retina during experimental and human diabetes. Early onset and effect of insulin.
The Journal of clinical investigation. 1998;102(4):783-91.
23.
Byeon SH, Chu YK, Lee H, Lee SY, Kwon OW. Foveal ganglion cell layer damage in ischemic
diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.
Ophthalmology. 2009;116(10):1949-59 e8.
24.
Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, et al. One-year
progression of diabetic subclinical macular edema in eyes with mild nonproliferative
diabetic retinopathy: location of the increase in retinal thickness. Ophthalmic research.
2015;54(3):118-23.
25.
Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA. Supplemental oxygen
improves diabetic macular edema: a pilot study. Investigative ophthalmology & visual
science. 2004;45(2):617-24.
26.
Ebneter A, Wolf S, Abhishek J, Zinkernagel MS. RETINAL LAYER RESPONSE TO RANIBIZUMAB
DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better. Retina (Philadelphia,
Pa). 2016;36(7):1314-23.
27.
Diabetic Retinopathy Clinical Research N, Wells JA, Glassman AR, Ayala AR, Jampol
LM, Aiello LP, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular
edema. The New England journal of medicine. 2015;372(13):1193-203.
28.
Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence
tomography of retinal pathology. American journal of ophthalmology. 2005;139(1):18-29.
29.
Lammer J, Scholda C, Prunte C, Benesch T, Schmidt-Erfurth U, Bolz M. Retinal thickness
and volume measurements in diabetic macular edema: a comparison of four optical coherence
tomography systems. Retina (Philadelphia, Pa). 2011;31(1):48-55.